Junrong Ma

612 total citations
14 papers, 509 citations indexed

About

Junrong Ma is a scholar working on Molecular Biology, Neurology and Oncology. According to data from OpenAlex, Junrong Ma has authored 14 papers receiving a total of 509 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Neurology and 3 papers in Oncology. Recurrent topics in Junrong Ma's work include Neurofibromatosis and Schwannoma Cases (4 papers), Bone health and treatments (3 papers) and Bone Tumor Diagnosis and Treatments (2 papers). Junrong Ma is often cited by papers focused on Neurofibromatosis and Schwannoma Cases (4 papers), Bone health and treatments (3 papers) and Bone Tumor Diagnosis and Treatments (2 papers). Junrong Ma collaborates with scholars based in China, United States and Canada. Junrong Ma's co-authors include Xijie Yu, Mingliang Zhou, Janet M. Hock, Meng Gong, Mi Li, Shiju Chen, Xiang Chen, Li Liu, Wen Yi and Bryan Maloney and has published in prestigious journals such as Neuron, Bone and Journal of Orthopaedic Research®.

In The Last Decade

Junrong Ma

14 papers receiving 499 citations

Peers

Junrong Ma

MB

CR

PHYSI

ONCOL

NEURO

Eliot J. Davidowitz United States

Monica K. Wetzel United States

Yunhe Gu China

Fenghua Zhou China

Sara Cioffi Italy

Lunshan Xu China

Sai Latha Shankar United States

Theresa L. Wellman United States

Caterina Fusilli Italy

Ranjithmenon Muraleedharan United States

Eliot J. Davidowitz United States

Junrong Ma

492 ×1.7

MB

359 ×1.7

CR

128 ×1.1

PHYSI

99 ×1.3

ONCOL

39 ×0.6

NEURO

Citations per year, relative to Junrong Ma Junrong Ma (= 1×) peers Eliot J. Davidowitz

Countries citing papers authored by Junrong Ma

Since Specialization

Citations

This map shows the geographic impact of Junrong Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junrong Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junrong Ma more than expected).

Fields of papers citing papers by Junrong Ma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junrong Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junrong Ma. The network helps show where Junrong Ma may publish in the future.

Co-authorship network of co-authors of Junrong Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Junrong Ma. A scholar is included among the top collaborators of Junrong Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junrong Ma. Junrong Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

1.

Ma, Junrong, Man He, Beibei Chen, & Bin Hu. (2023). Droplet microfluidic chip-ICP–MS-based single-cell analysis for study of cellular behavior of macrophages to thimerosal. Metallomics. 15(4). 3 indexed citations

2.

Zhao, Qian, Ping Li, Junrong Ma, & Xijie Yu. (2015). MicroRNAs in Lung Cancer and Lung Cancer Bone Metastases: Biomarkers for Early Diagnosis and Targets for Treatment. Recent Patents on Anti-Cancer Drug Discovery. 10(2). 182–200. 16 indexed citations

3.

Zhao, Qian, et al.. (2015). Bone Metastasis-Related MicroRNAs: New Targets for Treatment?. Current Cancer Drug Targets. 15(8). 716–725. 6 indexed citations

4.

Gong, Meng, Junrong Ma, Mingliang Zhou, et al.. (2013). MiR-335 Inhibits Small Cell Lung Cancer Bone Metastases via IGF-IR and RANKL Pathways. Molecular Cancer Research. 12(1). 101–110. 74 indexed citations

5.

Zhou, Mingliang, Junrong Ma, Shiju Chen, Xiang Chen, & Xijie Yu. (2013). MicroRNA-17-92 cluster regulates osteoblast proliferation and differentiation. Endocrine. 45(2). 302–310. 65 indexed citations

6.

Gong, Meng, Junrong Ma, Mi Li, et al.. (2012). MicroRNA-204 critically regulates carcinogenesis in malignant peripheral nerve sheath tumors. Neuro-Oncology. 14(8). 1007–1017. 54 indexed citations

7.

Ma, Junrong, Mi Li, Qinghua Zhou, et al.. (2011). Double suicide genes driven by kinase domain insert containing receptor promoter selectively kill human lung cancer cells. PubMed. 9(1). 6–6. 6 indexed citations

8.

Ma, Junrong, Mi Li, Janet M. Hock, & Xijie Yu. (2011). Hyperactivation of mTOR critically regulates abnormal osteoclastogenesis in neurofibromatosis type 1. Journal of Orthopaedic Research®. 30(1). 144–152. 16 indexed citations

9.

Chai, Guolin, Ning Liu, Junrong Ma, et al.. (2010). MicroRNA‐10b regulates tumorigenesis in neurofibromatosis type 1. Cancer Science. 101(9). 1997–2004. 82 indexed citations

10.

Ma, Junrong, et al.. (2010). Loss-of-function of SHARPIN causes an osteopenic phenotype in mice. Bone. 47. S398–S398. 4 indexed citations

11.

Yu, Xijie, et al.. (2010). Abnormal osteoblast development from Nf1 null embryonic stem cells. Bone. 47. S365–S365. 1 indexed citations

12.

Xia, Tian, Yanhua Liang, Junrong Ma, et al.. (2010). Loss-of-function of SHARPIN causes an osteopenic phenotype in mice. Endocrine. 39(2). 104–112. 17 indexed citations

13.

Yu, Xijie, Junrong Ma, & Janet M. Hock. (2010). Hyperactivation of mTOR critically regulates abnormal osteoclastogenesis in neurofibromatosis Type 1. Bone. 47. S360–S360. 1 indexed citations

14.

Yi, Wen, Wai Haung Yu, Bryan Maloney, et al.. (2008). Transcriptional Regulation of β-Secretase by p25/cdk5 Leads to Enhanced Amyloidogenic Processing. Neuron. 57(5). 680–690. 164 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact